4-Amino-benzoic acid 2-methoxy-ethyl esteroxalic acid salt, 1g

2,2-Dimethylhexanenitrile>98.0%(GC)5g

Tolfenamic Acid, 98.0%, 25g

4-(1H-tetrazol-5-yloxy)aniline, 95.0%, 5g

6-Methoxyquinoline 1-oxide, 97%, 250mg

Methyl 3-(piperidin-4-ylcarbamoyl)benzoate hydrochloride, 95.0%, 500mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(pyridin-3-yl)phenyl)propanoic acid, 97%, 5g

Syringe filters ROTILABO® Regenerated cellulose (RC), 0,2 µm, 25 mm, Non-sterile, 100 Piece(s)

Methyl (S)-3-bromo-2-methylpropanoate, 97.0%, 5g

N,N-Bis(2-hydroxyethyl)-2-aminoethanesulfonic Acid [Good's buffer component for biological research]>98.0%(T)25g

3-Methyl-6-(4-methyl-3-nitrophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-amine, 97%, 100mg

6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide, 99+%, 100mg

2-Methyl-1-propanol, ROTIPURAN®, min. 99%, pa, ACS, 1 l, glass packaging